NS · Healthcare

Concord Drugs Ltd (538965)

Pharmaceuticals & Biotechnology

Concord Drugs Ltd (538965) is listed on NS in the Healthcare sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $760.00M, P/E ratio is 73.08, net margin is 1.1%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 538965

Market cap

$760.00M

P/E ratio

73.08

Net margin

1.1%

Concord Drugs Ltd (538965) — FAQ

What is Concord Drugs Ltd's market cap?

Concord Drugs Ltd (538965) has a reported market cap of $760.00M (data as of 2026-07-10).

What is 538965's P/E ratio?

The price-to-earnings (P/E) ratio for Concord Drugs Ltd (538965) is 73.08 (data as of 2026-07-10).

Does Concord Drugs Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Concord Drugs Ltd (538965). Check the MyAverix Finance app for the latest dividend data.

What sector is Concord Drugs Ltd in?

Concord Drugs Ltd (538965) is classified in the Healthcare sector (Pharmaceuticals & Biotechnology industry).

What exchange is 538965 listed on?

538965 is listed on NS.

What is Concord Drugs Ltd's net margin?

Concord Drugs Ltd (538965) reports a net margin of 1.1% (data as of 2026-07-10).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

09R (09R) 10X GENOMICS DL -00001 (1KJ) 160 Health International Ltd (2656) 1CM INC. (IQ70) 2cureX AB (2CUREX) 3-D Matrix Ltd (DMTRF) 3D Global Biotech Inc. (6808) 3D Medicines Inc (1244)